Literature DB >> 32712830

Cell wall glycolipids from Corynebacterium pseudotuberculosis strains with different virulences differ in terms of composition and immune recognition.

Miriam Flores Rebouças1, Dan Loureiro1, Thiago Doria Barral1, Nubia Seyffert2, José Tadeu Raynal1, Thiago Jesus Sousa3, Henrique Cesar Pereira Figueiredo4, Vasco Azevedo3, Roberto Meyer1, Ricardo Wagner Portela5.   

Abstract

Caseous lymphadenitis (CLA) is an infectious disease caused by Corynebacterium pseudotuberculosis in small ruminants and is characterized by the development of granulomas in the lymph nodes, spleen, liver, and lungs. Although little is known about the host-pathogen relationship of this bacterium, it was previously reported that the pathogen's lipids are important for its taxonomic classification and survival inside macrophages. However, there are no studies regarding the composition of these molecules. In this study, cell wall glycolipids from two C. pseudotuberculosis strains presenting different virulence profiles were purified and its composition was characterized. A difference was observed between the electrophoretic and chromatogram profiles for cell wall components from the two strains, mainly among molecules with low molecular weights. IgM from sheep with acute CLA recognized antigens with an estimated molecular weight of 11 kDa of the low-pathogenicity strain, while low-molecular weight antigens from the high-pathogenicity strain presented a lower recognition by these antibodies. Mass spectrometry analysis showed that the cell wall of the high-pathogenicity strain contained glycolipids with high amounts of unsaturated fatty acids and glycerophosphoinositols, which may contribute to the capacity of this strain to cause severe disease. In conclusion, it is indicated that cell wall non-protein antigens can play a key role in C. pseudotuberculosis virulence.

Entities:  

Keywords:  Acute infection; Attenuated strains; Caseous lymphadenitis; Glycoconjugates; Microbial virulence

Mesh:

Substances:

Year:  2020        PMID: 32712830      PMCID: PMC7688822          DOI: 10.1007/s42770-020-00343-9

Source DB:  PubMed          Journal:  Braz J Microbiol        ISSN: 1517-8382            Impact factor:   2.476


  44 in total

1.  Structure of the cell envelope of corynebacteria: importance of the non-covalently bound lipids in the formation of the cell wall permeability barrier and fracture plane.

Authors:  Virginie Puech; Mohamed Chami; Anne Lemassu; Marie-Antoinette Lanéelle; Bettina Schiffler; Pierre Gounon; Nicolas Bayan; Roland Benz; Mamadou Daffé
Journal:  Microbiology (Reading)       Date:  2001-05       Impact factor: 2.777

2.  Carnitine.

Authors:  G FRAENKEL; S FRIEDMAN
Journal:  Vitam Horm       Date:  1957       Impact factor: 3.421

3.  Role of unsaturated fatty acid biosynthesis in virulence of Streptococcus mutans.

Authors:  Elizabeth M Fozo; Kathy Scott-Anne; Hyun Koo; Robert G Quivey
Journal:  Infect Immun       Date:  2007-01-12       Impact factor: 3.441

4.  Examination by electron microscopy of the interaction between peritoneal phagocytes and Corynebacterium ovis.

Authors:  G C Hard
Journal:  J Med Microbiol       Date:  1972-11       Impact factor: 2.472

Review 5.  The role of corynomycolic acids in Corynebacterium-host interaction.

Authors:  Andreas Burkovski
Journal:  Antonie Van Leeuwenhoek       Date:  2018-02-12       Impact factor: 2.271

Review 6.  Mycobacterial lipoarabinomannans: modulators of dendritic cell function and the apoptotic response.

Authors:  Jérôme Nigou; Martine Gilleron; Mauricio Rojas; Luis F García; Martin Thurnher; Germain Puzo
Journal:  Microbes Infect       Date:  2002-07       Impact factor: 2.700

7.  Enhanced protective immunity against malaria by vaccination with a recombinant adenovirus encoding the circumsporozoite protein of Plasmodium lacking the GPI-anchoring motif.

Authors:  Oscar Bruna-Romero; Carolina D Rocha; Moriya Tsuji; Ricardo T Gazzinelli
Journal:  Vaccine       Date:  2004-09-09       Impact factor: 3.641

8.  Characterization of strains of corynebacterium pseudotuberculosis.

Authors:  C A Muckle; C L Gyles
Journal:  Can J Comp Med       Date:  1982-04

9.  Mycobacterium tuberculosis arabinomannan-protein conjugates protect against tuberculosis.

Authors:  Beston Hamasur; Melles Haile; Andrzej Pawlowski; Ulf Schröder; Ann Williams; Graham Hatch; Graham Hall; Philip Marsh; Gunilla Källenius; Stefan B Svenson
Journal:  Vaccine       Date:  2003-09-08       Impact factor: 3.641

10.  Virulent and avirulent strains of Toxoplasma gondii which differ in their glycosylphosphatidylinositol content induce similar biological functions in macrophages.

Authors:  Sebastian Niehus; Terry K Smith; Nahid Azzouz; Marco A Campos; Jean-François Dubremetz; Ricardo T Gazzinelli; Ralph T Schwarz; Françoise Debierre-Grockiego
Journal:  PLoS One       Date:  2014-01-28       Impact factor: 3.240

View more
  1 in total

1.  Chemokine production induced by Corynebacterium pseudotuberculosis in a murine model.

Authors:  Thiago Doria Barral; Miriam Flores Rebouças; Dan Loureiro; José Tadeu Raynal; Thiago Jesus Sousa; Lilia Ferreira Moura-Costa; Vasco Azevedo; Roberto Meyer; Ricardo Wagner Portela
Journal:  Braz J Microbiol       Date:  2022-02-09       Impact factor: 2.214

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.